Related Experiment Video

Updated: Mar 23, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A

Yandong Lu1, Fangguo Li, Tao Xu

  • 1Department of Orthopaedic Traumatology, Tianjin Hospital, Tianjin, China.

Oncology Research
|April 8, 2016
PubMed

Insights

MicroRNA-497 (miR-497) acts as a tumor suppressor in chondrosarcoma (CHS), a common bone cancer. It inhibits cancer cell growth and promotes apoptosis by targeting Cdc25A, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chondrosarcoma (CHS) is the second most common primary malignant bone tumor.
  • Mechanisms regulating CHS progression, invasion, and metastasis are not fully understood.
  • Identifying novel regulatory factors is crucial for understanding CHS tumorigenesis.

Purpose of the Study:

  • To investigate the role of microRNA-497 (miR-497) in regulating chondrosarcoma cell growth and cell cycle.
  • To determine if miR-497 functions as a tumor suppressor in CHS.
  • To identify the molecular targets and pathways regulated by miR-497 in CHS.

Main Methods:

  • Reverse transcription-quantitative polymerase chain reaction (RT-PCR) to assess miR-497 expression.
  • Cell Counting Kit-8 (CCK-8) assay to evaluate cell proliferation.
  • Flow cytometry to analyze apoptosis.
  • Bioinformatics and luciferase reporter assays to identify miR-497 targets.

Main Results:

  • miR-497 expression was significantly downregulated in human chondrosarcoma tissues and cell lines.
  • Overexpression of miR-497 suppressed chondrosarcoma cell proliferation and induced apoptosis.
  • Repression of miR-497 promoted cell proliferation and inhibited apoptosis.
  • Cdc25A was identified as a direct target of miR-497.
  • miR-497 regulates chondrosarcoma cell growth via Cdc25A and p21 in a p53-independent manner.

Conclusions:

  • miR-497 acts as a tumor suppressor in human chondrosarcoma.
  • miR-497 regulates chondrosarcoma cell growth and cell cycle arrest by targeting Cdc25A.
  • This finding suggests miR-497 as a potential therapeutic target for chondrosarcoma treatment.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K